Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
W. Trzepizur, F. Gagnadoux, P. Abraham, M. L. Mastronardi, A. A. Agouni, N. Meslier, G. Leftheriotis, J. L. Saumet, J. L. R. Racineux, M. C. M. Martinez, R. A. Andriantsitohaina (Angers, France). Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome. Eur Respir J 2008; 32: Suppl. 52, 3230

Member's Comments

No comment yet.

Related content which might interest you: Microparticles and vascular dysfunction in obstructive sleep apnoea Source: Eur Respir J 2014; 44: 207-216 Year: 2014 Endothelial function in obstructive sleep apnea syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Endothelial dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Influence of micropaticles harvested from patients affected by obstructive sleep apnea syndrome on endothelial function and vascular reactivity Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009 Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Source: Eur Respir J 2009; 33: 574-580 Year: 2009 Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults Year: 2020 Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Decreased circulating endothelial progenitor cells in obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004 The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005 Markers of liver dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Sleep apnea and endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 Vascular reactivity in patients with mild-moderate obstructive sleep apnoea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Mechanisms and assessment of vascular damage in obstructive sleep apnoea Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea” Year: 2013